Exact Mass: 412.0925

Exact Mass Matches: 412.0925

Found 64 metabolites which its exact mass value is equals to given mass value 412.0925, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Patientoside A

1-(4-chloro-1-hydroxy-3-methyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethan-1-one

C19H21ClO8 (412.0925)

Patientoside A is found in herbs and spices. Patientoside A is a constituent of the roots of Rumex patientia (patience dock). Constituent of the roots of Rumex patientia (patience dock). Patientoside A is found in herbs and spices.

Zileuton O-glucuronide

(2S,3S,4S,5R,6S)-6-({[1-(1-benzothiophen-2-yl)ethyl](C-hydroxycarbonimidoyl)amino}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H20N2O8S (412.094)

Zileuton O-glucuronide is a metabolite of zileuton. Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation. Zileuton is used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names ZYFLO and ZYFLO CR. The original immediate-release formulation of zileuton, known as ZYFLO, is taken four times per day. (Wikipedia)

4,7-Diphenyl-1,10-phenanthrolinesulphonic acid

4,7-diphenyl-1,10-phenanthroline-2-sulfonic acid

C24H16N2O3S (412.0882)

4-Amino-5-methylamino-2',7'-difluorescein

4-amino-2,7-difluoro-3,6-dihydroxy-5-(methylamino)-3H-spiro[2-benzofuran-1,9-xanthene]-3-one

C21H14F2N2O5 (412.0871)

Cys Cys Gly Met

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C13H24N4O5S3 (412.0909)

Cys Cys Met Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]acetic acid

C13H24N4O5S3 (412.0909)

Cys Gly Cys Met

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C13H24N4O5S3 (412.0909)

Cys Gly Met Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C13H24N4O5S3 (412.0909)

Cys Met Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]acetic acid

C13H24N4O5S3 (412.0909)

Cys Met Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-sulfanylpropanoic acid

C13H24N4O5S3 (412.0909)

Gly Cys Cys Met

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C13H24N4O5S3 (412.0909)

Gly Cys Met Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C13H24N4O5S3 (412.0909)

Gly Met Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H24N4O5S3 (412.0909)

Met Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C13H24N4O5S3 (412.0909)

Met Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C13H24N4O5S3 (412.0909)

Met Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H24N4O5S3 (412.0909)

Patientoside A

1-(4-chloro-1-hydroxy-3-methyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethan-1-one

C19H21ClO8 (412.0925)

(1-METHYL-1H-PYRROL-2-YL)METHYLAMINE

C23H26BrP (412.0955)

1-Chloro-9,10-bis(phenylethynyl)anthracene

C30H17Cl (412.1019)

1,5-Pentanediol,1,5-bis(4-methylbenzenesulfonate)

C19H24O6S2 (412.1014)

1-(Phenylsulfonyl)indole-2-boronic acid MIDA ester,1-(Phenylsulfonyl)indole-2-boronic acid,Methyliminodiacetic acid anhydride

C19H17BN2O6S (412.09)

isoamyltriphenylphosphonium bromide

C23H26BrP (412.0955)

9,10-bis-(Phenylethynyl)-2-chloroanthracene

C30H17Cl (412.1019)

1,3-bis(tosyloxy)-2,2-dimethylpropane

C19H24O6S2 (412.1014)

MES hemisodium salt

C12H25N2NaO8S2 (412.095)

Pentyltriphenylphosphonium bromide

C23H26BrP (412.0955)

3-nitro-4-(2-(3-phenoxybenzylidene)hydrazinyl)benzenesulfonamide

C19H16N4O5S (412.0841)

4-{3-Chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-hydroxy-6-quinolinecarboxamide

C20H17ClN4O4 (412.0938)

Ethyl 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylate acetate (1:1)

C17H20N2O8S (412.094)

DL-threo-2-methylisocitrate

C14H20O14 (412.0853)

methyl 3-(4-methylsulfonylphenoxy)-5-phenylmethoxybenzoate

C22H20O6S (412.0981)

Chitobiose

chitobiose dihydrochloride

C12H26Cl2N2O9 (412.1015)

Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated. [HMDB]

4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione

C22H21ClN2O2S (412.1012)

(2s,3s,6r,8r)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione

C22H21ClN2O2S (412.1012)

(2r,3s,4s)-4-(benzylsulfanyl)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C22H20O6S (412.0981)

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[(2-oxo-5h-furan-3-yl)methoxy]oxan-2-yl]methyl 3,4-dihydroxybenzoate

C18H20O11 (412.1006)

1-(4-chloro-1-hydroxy-3-methyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethanone

C19H21ClO8 (412.0925)

2,3,4,9-tetrahydroxy-2-methyl-5,10-dioxo-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluoren-1-yl acetate

C20H16N2O8 (412.0907)

(2s,3s,6s,8r)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione

C22H21ClN2O2S (412.1012)